Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Eur J Immunol ; 45(4): 1103-15, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25627813

RESUMEN

The serine/threonine kinase glycogen synthase kinase-3 (GSK3) plays an important role in balancing pro- and anti-inflammatory cytokines. We have examined the role of GSK3 in production of IL-10 by subsets of CD4(+) T helper cells. Treatment of naive murine CD4(+) T cells with GSK3 inhibitors did not affect their production of IL-10. However, treatment of Th1 and Th2 cells with GSK3 inhibitors dramatically increased production of IL-10. GSK3 inhibition also led to upregulation of IL-10 among Th1, Th2, and Th17 subsets isolated from human blood. The encephalitogenic potential of GSK3 inhibitor treated murine Th1 cells was significantly reduced in adoptive transfer experiments by an IL-10-dependent mechanism. Analysis of the murine IL-10 promoter in response to inhibition of GSK3 in Th1 cells showed modification to a transcriptionally active state indicated by changes in histone H3 acetylation and methylation. Additionally, GSK3 inhibition increased expression of the transcription factors c-Maf, Nfil3, and GATA3, correlating with the increase in IL-10. These findings are important in the context of autoimmune disease since they show that it is possible to reprogram disease-causing cells through GSK3 inhibition.


Asunto(s)
Glucógeno Sintasa Quinasa 3/metabolismo , Interleucina-10/biosíntesis , Células TH1/inmunología , Células Th17/inmunología , Células Th2/inmunología , Acetilación , Traslado Adoptivo , Animales , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/biosíntesis , Células Cultivadas , Células Dendríticas/inmunología , Encefalomielitis Autoinmune Experimental/inmunología , Factor de Transcripción GATA3/biosíntesis , Glucógeno Sintasa Quinasa 3/antagonistas & inhibidores , Histonas/metabolismo , Humanos , Inflamación/inmunología , Interleucina-10/genética , Metilación , Ratones , Ratones Noqueados , Regiones Promotoras Genéticas , Proteínas Proto-Oncogénicas c-maf/biosíntesis , Células TH1/trasplante
2.
Front Immunol ; 4: 129, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23755052

RESUMEN

Since the discovery of interleukin-10 (IL-10) in the 1980s, a large body of work has led to its recognition as a pleiotropic immunomodulatory cytokine that affects both the innate and adaptive immune systems. IL-10 is produced by a wide range of cell types, but for the purposes of this review we shall focus on IL-10 secreted by CD4(+) T cells. Here we describe the importance of IL-10 as a mediator of suppression used by both FoxP3(+) and FoxP3(-) T regulatory cells. Moreover, we discuss the molecular events leading to the induction of IL-10 secretion in T helper cell subsets, where it acts as a pivotal negative feedback mechanism. Finally we discuss how a greater understanding of this principle has allowed for the design of more efficient, antigen-specific immunotherapy strategies to exploit this natural phenomenon clinically.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA